CN108159276A - 一种熏蒸液及其制备方法和使用方法 - Google Patents
一种熏蒸液及其制备方法和使用方法 Download PDFInfo
- Publication number
- CN108159276A CN108159276A CN201810075346.6A CN201810075346A CN108159276A CN 108159276 A CN108159276 A CN 108159276A CN 201810075346 A CN201810075346 A CN 201810075346A CN 108159276 A CN108159276 A CN 108159276A
- Authority
- CN
- China
- Prior art keywords
- raw material
- preparation
- fumigation liquid
- radix
- fumigation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000003958 fumigation Methods 0.000 title claims abstract description 59
- 239000007788 liquid Substances 0.000 title claims abstract description 55
- 238000000034 method Methods 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 39
- 230000001954 sterilising effect Effects 0.000 claims description 27
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 26
- 238000004659 sterilization and disinfection Methods 0.000 claims description 25
- 239000000284 extract Substances 0.000 claims description 21
- 238000000605 extraction Methods 0.000 claims description 18
- 238000005516 engineering process Methods 0.000 claims description 14
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 13
- 239000001569 carbon dioxide Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 13
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 7
- 235000021419 vinegar Nutrition 0.000 claims description 7
- 239000000052 vinegar Substances 0.000 claims description 7
- 235000020097 white wine Nutrition 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000010025 steaming Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 48
- 239000003814 drug Substances 0.000 abstract description 43
- 229940079593 drug Drugs 0.000 abstract description 16
- 230000017531 blood circulation Effects 0.000 abstract description 10
- 230000001737 promoting effect Effects 0.000 abstract description 10
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract description 7
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract description 7
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 abstract description 7
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 abstract description 6
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract description 6
- 241000758794 Asarum Species 0.000 abstract description 6
- 235000016811 Biondella Nutrition 0.000 abstract description 6
- 241001313857 Bletilla striata Species 0.000 abstract description 6
- 244000020518 Carthamus tinctorius Species 0.000 abstract description 6
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract description 6
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract description 6
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract description 6
- 208000008454 Hyperhidrosis Diseases 0.000 abstract description 6
- 241000195947 Lycopodium Species 0.000 abstract description 6
- 244000246386 Mentha pulegium Species 0.000 abstract description 6
- 235000016257 Mentha pulegium Nutrition 0.000 abstract description 6
- 235000004357 Mentha x piperita Nutrition 0.000 abstract description 6
- 235000003143 Panax notoginseng Nutrition 0.000 abstract description 6
- 241000180649 Panax notoginseng Species 0.000 abstract description 6
- 240000004980 Rheum officinale Species 0.000 abstract description 6
- 235000008081 Rheum officinale Nutrition 0.000 abstract description 6
- 241001165494 Rhodiola Species 0.000 abstract description 6
- 241001530209 Swertia Species 0.000 abstract description 6
- 241000830536 Tripterygium wilfordii Species 0.000 abstract description 6
- 206010047700 Vomiting Diseases 0.000 abstract description 6
- 230000000202 analgesic effect Effects 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 6
- 229940116229 borneol Drugs 0.000 abstract description 6
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract description 6
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract description 6
- 235000001050 hortel pimenta Nutrition 0.000 abstract description 6
- 235000015398 thunder god vine Nutrition 0.000 abstract description 6
- 230000008673 vomiting Effects 0.000 abstract description 6
- 230000033228 biological regulation Effects 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 4
- 230000001939 inductive effect Effects 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 230000001684 chronic effect Effects 0.000 abstract description 3
- 231100000614 poison Toxicity 0.000 abstract description 3
- 240000007890 Leonurus cardiaca Species 0.000 abstract description 2
- 208000013219 diaphoresis Diseases 0.000 abstract description 2
- 230000029142 excretion Effects 0.000 abstract description 2
- 230000007096 poisonous effect Effects 0.000 abstract description 2
- 235000014571 nuts Nutrition 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 22
- 239000008280 blood Substances 0.000 description 22
- 208000002193 Pain Diseases 0.000 description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 201000010099 disease Diseases 0.000 description 12
- 239000000796 flavoring agent Substances 0.000 description 12
- 235000019634 flavors Nutrition 0.000 description 12
- 208000017667 Chronic Disease Diseases 0.000 description 9
- 208000006820 Arthralgia Diseases 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 7
- 230000003750 conditioning effect Effects 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 201000004624 Dermatitis Diseases 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 230000000144 pharmacologic effect Effects 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 201000000736 Amenorrhea Diseases 0.000 description 5
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 206010013935 Dysmenorrhoea Diseases 0.000 description 5
- 241000207925 Leonurus Species 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 208000014617 hemorrhoid Diseases 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 208000000616 Hemoptysis Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 206010000269 abscess Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 210000003800 pharynx Anatomy 0.000 description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 201000005569 Gout Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 241000521257 Hydrops Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 238000000889 atomisation Methods 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 239000000446 fuel Substances 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000003821 menstrual periods Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000001839 systemic circulation Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 231100000925 very toxic Toxicity 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- 235000014101 wine Nutrition 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001260012 Bursa Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 208000004929 Facial Paralysis Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010044684 Trismus Diseases 0.000 description 1
- 206010061577 Ulcer haemorrhage Diseases 0.000 description 1
- 206010046555 Urinary retention Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000007791 dehumidification Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000001097 facial muscle Anatomy 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000027498 hoarse voice Diseases 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000004084 narcotic analgesic agent Substances 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 235000012771 pancakes Nutrition 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 230000020341 sensory perception of pain Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000000015 thermotherapy Methods 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种熏蒸液及其制备方法和使用方法。该熏蒸液的制备原料包含防风、西红花、伸筋草、白芨、龙胆草、马钱子、雷公藤、桂枝、三七、大黄、草乌、甘草、红景天、细辛、薄荷、黄柏、当归、白芍、丹参、益母草和冰片。以上原料符合中华人民共和国药典规定,药物安全可靠,诸药相和具有芳香开窍、行气活血、消肿、消炎、止痛、解表去邪、祛风去湿、排泄体内有毒有害物质、恢复机体能力的功效,特别使用于慢性病患者与亚健康人群,具有疗效确切、见效显著、治疗方便简单,无任何副毒作用等优点。
Description
技术领域
本发明涉及中医药技术领域,尤其涉及一种熏蒸液及其制备方法和使用方法。
背景技术
慢性病是病理变化缓慢或不能在短时期内治好的一类疾病的总称,例如类风湿性关节炎、腰肌劳损、湿疹、膀胱炎、痔疮等疾病。它具有治疗周期长的特点。由于慢性病不易治愈,长期服用口服药会对患者的肾脏、肝脏、胃肠道等造成一定程度上的损伤,有的甚至会引起患者食欲下降、体重减轻、精神萎靡等。
亚健康状态是健康与疾病之间的临界状态,是机体在无器质性病变情况下发生了一些功能性病变,其临床表现多种多样,但临床检查无异常,并且不能确诊为疾病。据统计,在我国有60~70%的人群处于亚健康状态,已是当今危害人们健康的头号隐形杀手。但是亚健康状态的发生机制尚未完全明确,现代医学对其亦无较好的防治办法。
中药熏蒸疗法(又称被称为中药蒸煮疗法或中药汽浴疗法),是以热药蒸汽为治疗因子的一种化学、物理综合疗法。它通过对中药液体的加热,使中药液产生富含中药离子的蒸汽。患者在熏蒸治疗时,由于蒸汽热敷的作用,毛孔张开,毛细血管网开放,在蒸汽环境内,机体内邪外出,中药有效成份经皮肤吸收,对患病部位和经络病变区进行有效渗透,药力直达病灶。而且,中药熏蒸时的温热和药物双重效应还可以将患者体内有毒物质排出体外。
目前对于慢性病和亚健康患者的治疗主要是采用药物进行治疗,虽然在短期内具有一定的疗效,但长期服药会导致患者身体机能下降。基于此,发明人结合中药熏蒸疗法,研发出了一种用于治疗上述疾病的熏蒸液,解决了市面上鲜有针对慢性病和亚健康人群的熏蒸药物的问题。
发明内容
(一)要解决的技术问题
针对上述技术问题,本发明提供了一种熏蒸液及其制备方法和使用方法。
(二)技术方案
为了解决上述技术问题,本发明提供了如下技术方案:
一种熏蒸液,制备原料包含:
优选地:制备原料包含:
优选地:制备原料包含:
一种熏蒸液的制备方法,包括如下步骤:
(1)将制备原料洗净、烘干,然后进行灭菌处理;
(2)将制备原料粉碎;
(3)利用二氧化碳超临界萃取技术对粉碎后的制备原料进行萃取,得到萃取物;和
(4)将萃取物和白酒混合,将混合物静置,然后过滤,收集滤液并进行灭菌处理,得到熏蒸液。
优选地:在步骤(1)中,采用臭氧进行所述灭菌处理。
优选地:在步骤(1)中,将制备原料置于无菌室中,用臭氧进行灭菌处理,并且灭菌时间控制在30~60分钟。
优选地:在步骤(3)中,所述二氧化碳超临界萃取技术的工艺条件为:
萃取温度:40~50℃;
萃取压力:20~30MPa;
萃取时间:1~2h。
优选地:在步骤(4)中,所述白酒和所述萃取物的质量比为
(10~20):1。
优选地:在步骤(4)中,将所述混合物静置1~3个月。
一种熏蒸液的使用方法,将所述熏蒸液与醋按照1:(8~10)的体积比混合,将混合物放入熏蒸用装置中并进行加热。
(三)有益效果
本发明的上述技术方案具有如下优点:
(1)本发明提供的熏蒸液对于慢性病和亚健康人群具有显著的治疗效果,经济实惠、不易复发且对人体无损伤。
(2)本发明采用二氧化碳超临界萃取技术提取药材中的有效成分,萃取能力强、成分提取率高(萃取率高达95%),药性效果好,有效成分几乎完全提取(提取物中的有效成分含量大于95wt%),还可以有效去除有害部分如:农药、化肥、重金属等残留,从而大大增强中药的药性,疗效显著提高。经药理临床证明,二氧化碳超临界萃取技术进行提取不仅工艺上优越、质量稳定、标准容易控制,而且提取产物的临床疗效更加显著。
具体实施方式
为使本发明的目的、技术方案和优点更加清楚,下面将结合本发明实施例,对本发明的技术方案进行清楚、完整地描述。显然,所描述的实施例是本发明的一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动的前提下所获得的所有其他实施例,都属于本发明保护的范围。
本发明提供了一种熏蒸液,制备原料包含:
本发明提供的上述熏蒸液,所用的原料功效及作用如下:
防风:性温,味甘、辛,具有发表、祛风、除湿的功效,用于治疗感冒、头痛、发热、无汗、风湿痹痛、四肢拘挛、皮肤风湿瘙痒、破伤风等症。
西红花:性平,味甘,具有活血化淤、凉血解毒、解郁安神的功效,用于经闭症瘕、产后瘀阻、温毒发斑、忧郁痞闷、惊悸发狂。
伸筋草:性温,味微苦、辛,具有祛风寒、除湿消肿、舒筋活络的功效,用于风寒湿痹、关节酸痛、皮肤麻木、四肢软弱、水肿、跌打损伤。
白芨:性微寒,味苦、甘、涩,具有收敛止血、消肿生肌的功效,用治咳血吐血、肺结核咳血、溃疡病出血。
龙胆草:性寒,味苦,具有清肝火、除湿热、健胃的功效,用于治疗目赤头晕、耳聋耳肿、胁痛口苦、咽喉肿痛、惊痫抽搐、湿热疮毒、湿疹、阴肿、阴痒、小便淋痛、食欲不振。
马钱子:性温,味苦,有毒,具有清肺利咽、止血的功效,用治风热郁肺咽痛、咳嗽、音哑。
雷公藤:性寒,味辛、苦,有大毒,具有祛风除湿、通络止痛、活血消肿、杀虫解毒的功效,用于风湿顽痹、疔疮肿毒、腰带疮、麻风、顽癣。
桂枝:性温,味辛、甘,具有发汗解肌、温通经脉、助阳化气、平冲降气的功效,用于风寒感冒、脘腹冷痛、血寒经闭、关节痹痛、痰饮、水肿、心悸。
三七:性温,味甘、微苦,具有散瘀止血、消肿定痛的功效,用治咯血、吐血、衄血、便血、崩漏、外伤出血、胸腹刺痛、跌扑肿痛。
大黄:性寒,味苦,具有泻热通肠、凉血解毒、逐瘀通经的功效,用于实热便秘、积滞腹痛、泻痢不爽、湿热黄疸、血热吐衄、目赤、咽肿、肠痈腹痛、痈肿疔疮、瘀血经闭、跌打损伤。
草乌:性热,味辛、苦,有大毒,具有祛风除湿,温经止痛的功效,用于风寒湿痹,关节疼痛,心腹冷痛,寒疝作痛及麻醉止痛。
甘草:性平,味甘,具有补脾益气、清热解毒、祛痰止咳、缓急止痛的功效,用于脾胃虚弱、倦怠乏力、心悸气短、咳嗽痰多、脘腹、四肢挛急疼痛、痈肿疮毒。
红景天:性寒,味甘涩,具有活血止血、清肺止咳的功效,用于治疗咳血、咯血、肺炎咳嗽、妇女白带。
细辛:性温,味辛,小毒,具有散寒祛风、止痛、温肺化饮、通窍的功效,治风冷头痛、鼻渊、齿痛、痰饮咳逆、风湿痹痛。
薄荷:性凉,味辛,具有宣散风热、清头目、透疹的功效,用于风热感冒、风温初起、头痛、目赤、喉痹、口疮、风疹、麻疹、胸胁胀闷。
黄柏:性寒,味苦,具有清热燥湿、泻火除蒸、解毒疗疮的功效。用于湿热泻痢、黄疸、带下、热淋、脚气、骨蒸劳热、盗汗、遗精、疮疡肿毒、湿疹瘙痒。
当归:性辛、温,味甘,具有补血活血、调经止痛、润肠通便的功效,用于血虚萎黄、眩晕心悸、月经不调、经闭痛经、虚寒腹痛、肠燥便秘、风湿痹痛、跌扑损伤、痈疽疮疡。
白芍:性微寒,味苦、酸,具有补血敛阴、柔肝止痛、平降肝阴的功效,用于血虚萎黄、眩晕、经少经闭、敛阴止汗、阴虚盗汗、胁肋作痛、脘腹疼痛、手足拘挛作痛、头痛眩晕。
丹参:性微温,味苦,具有活血祛瘀、安神宁心、排脓、止痛的功效,治心绞痛、月经不调、痛经、经闭、血崩带下、癥瘕、积聚、瘀血腹痛、骨节疼痛、惊悸不眠、恶疮肿毒。
益母草:性微寒,味苦、辛,具有活血调经、利尿消肿的功效,用于月经不调、痛经、经闭、恶露不尽、水肿尿少。
冰片:性微寒,味辛、苦,具有开窍醒神、清热止痛的功效,用于热病神昏、痉厥、中风痰厥、气郁暴厥、中恶昏迷、目赤、口疮、咽喉肿痛、耳道流脓。
以上原料符合中华人民共和国药典规定,药物安全可靠,诸药相和具有芳香开窍、行气活血、消肿、消炎、止痛、解表去邪、祛风去湿、排泄体内有毒有害物质、恢复机体能力的功效,特别使用于慢性病患者与亚健康人群,具有疗效确切、见效显著、治疗方便简单,无任何副毒作用等优点。
采用纯天然中草药制成的熏蒸液无任何添加剂,对人体无任何副作用,操作简单方便,可用于慢性疾病与亚健康人群。而且,熏蒸液还避免了药物对人体口腔粘膜、消化道、胃肠黏膜的刺激与伤害,减轻肝肾脏的负担,药性强大效果明显,彻底解决慢性疾病与亚健康人群的健康问题。
使用时,配合中药透皮熏蒸液疗法,熏蒸装置可以选用调理舱(也可以选用其它具有通电加热功能的熏蒸装置),把熏蒸液放入仪器内,通电经过加热产生药液雾化。患者进入调理舱内,人体受热后,毛孔自然扩张,雾化后的熏蒸液经皮肤、毛孔、皮脂腺、腠理、粘膜、经脉进入人体发挥作用。同时仪器辐射出的10~13微米波段远红外线可在短时间内渗透人体内脏,引导熏蒸液进入体内发热共振,激活细胞,对人体消肿、消炎、灭菌,促进毛细血管扩张、活血化瘀、加速新陈代谢,清理体内湿、寒、热、气、血等毒素,增强机体免疫力与抵抗力具有显著效果,从而使慢性疾病患者恢复到亚健康,使亚健康人群恢复到健康状态。
作用机理如下:
中药熏蒸具有显著、强大、持久的生理、药理效应。产生这两个效应是熏蒸的热能与对症使用的药物。治疗过程中,热与药这一对治疗因子是相互影响、共同作用于机体产生协同增效作用的。热是一种物理因子,热疗属物理疗法的范畴。熏蒸过程的热效应是由源源不断的热药蒸汽以对流和传导的方式直接作用于人体的。而药疗效应是由熏蒸药物中逸出的中药粒子作用于体表直接产生杀虫、杀菌、消炎、止痒、治痛等作用,或是经透皮吸收人体通过激动组织细胞受体的生物化学过程发挥药疗作用。中药熏蒸过程中,丰富热能和大量药物持续作用于人体,使出现以下一系列生理、药理效应。其一是周身体表毛细血管网被充分扩张、开放,外周血容迅速增多,导致体内储血和内脏血液重新分布,进而促进全身血液大循环。这种因热能因子疏通腠理及产生的舒张血管、通达血脉、促进血液大循环的结果同时促进了当归、白芍、丹参、益母草等药物的渗透与吸收,而随着活血化瘀药物的吸收并发挥药效,又使因热效应产生的活血化瘀作用更加突出,更加持久。其二是低密度、易流动、热卡高、传热效果好的熟药蒸汽作用于人体所产生的“发汗”效应,可迅速排出体内多余水份及代谢废物,这对肾功能不全或其它原因导致的水肿或尿潴留病人显得尤为重要。在熏蒸过程中有选择地加入辛温中药,可在较低熏蒸强度条件下,强化发汗解衰过程。其三是神经、经络调节作用。中药熏蒸的热药效应绝不仅仅是产生皮肤的温热或药疗作用,而是导致一系列如情绪轻松、肌肉松弛,睡眠改善、身心舒畅等生理、心理变化;反应在内部脏器上,就是偏胜偏衰的脏器功能趋于协调、平衡;这就是神经与经络调节的结果。同时施用养血补气安神中药可促进和强化上述调节过程。其四是治痛。熏蒸治疗因子作用于感觉神经,可降低其兴奋性,使主观上的痛觉感受减轻。
优选地,各组分用量为:
进一步优选地,各组分用量为:
本发明还提供了一种熏蒸液的制备方法,包括如下步骤:
(1)将制备原料洗净、烘干,然后进行灭菌处理。在该步骤中,可以采用臭氧进行所述灭菌处理,具体包括如下步骤:将制备原料置于无菌室中,用臭氧进行灭菌处理,并且灭菌时间控制在30~60分钟。
(2)将制备原料粉碎。
(3)利用二氧化碳超临界萃取技术对粉碎后的制备原料进行萃取,得到萃取物。所述二氧化碳超临界萃取技术的工艺条件优选为:萃取温度:40~50℃;萃取压力:20~30MPa;萃取时间:1~2h。为了得到更好的萃取效果,可以多次萃取,优选地,将萃取次数控制在1~2次。
(4)将萃取物和白酒混合,两者的质量比可以为(10~20):1,例如10:1、15:1、20:1,将两者混合后得到的混合物静置一段时间,例如1~3个月,然后将混合物过滤,收集滤液并进行灭菌处理,得到熏蒸液。
本发明采用二氧化碳超临界萃取技术提取药材中的有效成分,萃取能力强、成分提取率高,药性效果好,有效成分几乎完全提取,还可以有效去除有害部分如:农药、化肥、重金属等残留,从而大大增强中药的药性,疗效显著提高。经药理临床证明,二氧化碳超临界萃取技术进行提取不仅工艺上优越、质量稳定、标准容易控制,而且提取产物的临床疗效更加显著。
本发明还提供了一种熏蒸液的使用方法,具体为:将所述熏蒸液与醋(如纳米醋)按照1:(8~10)的体积比混合,将混合物放入熏蒸用装置中并进行加热。例如,临床应用时,可以取所述熏蒸液50mL,加500mL纳米醋液混合,然后放入调理舱雾化器内,通电加热成雾化后,进入调理舱内进行中药熏蒸30分钟左右即可,每周使用1-2次。对关节、肌腱、筋膜及软组织的炎性改变等症,仅靠药物的体表作用显然是不够的。药物必须有效进入体内才能发挥进一步的治疗作用。熏蒸吸收药物的效果不仅与熏蒸液的浓度、熏蒸时间密切相关,还与所用的透皮促进剂或透皮增效剂有关。本发明提供的熏蒸液中的透皮促进剂为酒和醋。酒具有通血脉、引药性、助药力、行药势,可行气走窜于全身的作用,因其具有较好的水、脂兼溶性,又可扩张、通达血脉,最宜在治疗风、寒、湿引致的痹症或跌打损伤急性期后的化瘀消肿、活二止痛时运用。醋性酸、温,具有消痈肿、散水汽,杀邪毒之功效,在治疗皮肤的痈疽疮疡和颈、腰、足跟等骨质增生致痛时常用之,亦有很好发散药性、增加药效之功。
以下是本发明列举的实施例。
实施例1
制备原料包含:防风30g,西红花20g,伸筋草30g,白芨20g,龙胆草20g,马钱子10g,雷公藤10g,桂枝10g,三七20g,大黄10g,草乌20g,甘草10g,红景天30g,细辛10g,薄荷10g,黄柏10g,当归10g,白芍10g,丹参10g、益母草10g,冰片5g。
制备方法包括如下步骤:
将上述制备原料洗净、烘干,置于无菌室中,用臭氧进行灭菌处理,灭菌时间控制在30分钟。
将经上述处理后的制备原料粉碎。
利用二氧化碳超临界萃取技术对粉碎后的制备原料进行萃取,萃取工艺条件为:萃取温度:40℃;萃取压力:20MPa;萃取时间:2h,得到萃取物。
将萃取物和白酒按照1:10的质量比混合,将混合物静置1个月,然后过滤,收集滤液并进行灭菌处理,得到熏蒸液。
实施例2
制备原料包含:防风40g,西红花25g,伸筋草40g,白芨25g,龙胆草25g,马钱子15g,雷公藤15g,桂枝15g,三七25g,大黄15g,草乌25g,甘草15g,红景天40g,细辛15g,薄荷15g,黄柏15g,当归15g,白芍15g,丹参15g、益母草15g,冰片7.5g。
制备方法包括如下步骤:
将上述制备原料洗净、烘干,置于无菌室中,用臭氧进行灭菌处理,灭菌时间控制在40分钟。
将经上述处理后的制备原料粉碎。
利用二氧化碳超临界萃取技术对粉碎后的制备原料进行萃取,萃取工艺条件为:萃取温度:50℃;萃取压力:30MPa;萃取时间:1h,得到萃取物。
将萃取物和白酒按照1:12的质量比混合,将混合物静置2个月,然后过滤,收集滤液并进行灭菌处理,得到熏蒸液。
实施例3
制备原料包含:防风60g,西红花40g,伸筋草60g,白芨40g,龙胆草40g,马钱子20g,雷公藤20g,桂枝20g,三七40g,大黄20g,草乌40g,甘草20g,红景天60g,细辛20g,薄荷20g,黄柏20g,当归20g,白芍20g,丹参20g、益母草20g,冰片10g。
制备方法包括如下步骤:
将上述制备原料洗净、烘干,置于无菌室中,用臭氧进行灭菌处理,灭菌时间控制在50分钟。
将经上述处理后的制备原料粉碎。
利用二氧化碳超临界萃取技术对粉碎后的制备原料进行萃取,萃取工艺条件为:萃取温度:45℃;萃取压力:25MPa;萃取时间:1.5h,得到萃取物。
将萃取物和白酒按照1:15的质量比混合,将混合物静置3个月,然后过滤,收集滤液并进行灭菌处理,得到熏蒸液。
实施例4
制备原料包含:防风90g,西红花60g,伸筋草90g,白芨60g,龙胆草60g,马钱子30g,雷公藤30g,桂枝30g,三七60g,大黄30g,草乌60g,甘草30g,红景天90g,细辛30g,薄荷30g,黄柏30g,当归30g,白芍30g,丹参30g、益母草30g,冰片15g。
制备方法包括如下步骤:
将上述制备原料洗净、烘干,置于无菌室中,用臭氧进行灭菌处理,灭菌时间控制在60分钟。
将经上述处理后的制备原料粉碎。
利用二氧化碳超临界萃取技术对粉碎后的制备原料进行萃取,萃取工艺条件为:萃取温度:50℃;萃取压力:20MPa;萃取时间:2h,得到萃取物。
将萃取物和白酒按照1:20的质量比混合,将混合物静置3个月,然后过滤,收集滤液并进行灭菌处理,得到熏蒸液。
本发明提供的熏蒸液对于慢性病治疗作用的研究。
选择在2014年5月至2016年5月就诊的各类慢性病患者,确诊入组。其中,类风湿性关节炎组33例,痛风组21例,高血压组45例,痔疮组28例。患者年龄20~71岁。所有病例均排除严重的肝肾疾病、恶性肿瘤等严重的系统性疾病。
治疗前停止服用其它药物,采用实施例1制备的熏蒸液进行熏蒸,使用方法为:取熏蒸液50mL,加入500mL纳米醋液混合,然后放入调理舱雾化器内,通电加热成雾化后,进入调理舱内进行中药熏蒸30分钟,每周使用2次。
治疗28天后,判断临床疗效。
评价标准:疗效标准参照《中医病症判断疗效标准》中有关疗效标准。痊愈:临床症状全部消失,试验室检查正常。好转:临床症状减轻,实验室检查改善或正常。无效:临床症状无明显好转或加重。其中,痊愈率和好转率之和称为有效率。
具体结果见下表。
表1
现举典型病例如下:
患者刘某,46岁,有十几年患高血压症,长期服用西药,造成肝、肾功能受损。用实施例1制得的熏蒸液熏蒸一次后,血压比之前有所下降。经过多次调理后,停药至今,血压正常,肝、肾恢复正常功能。
患者王某,25岁,痛经,经量少,颜色发暗,经期延迟。用实施例1制得的熏蒸液熏蒸调理后一个疗程(28天)后,痛经症状消失,经量增加,经期恢复正常。
患者张某,34岁,外痔患者,使用实施例1制得的熏蒸液熏蒸调理后,当天外痔明显变小,排便正常。坚持一个疗程(28天),彻底痊愈。
患者秦某,63岁,多年痛风史,疼痛难忍,脚无法落地,脚趾红肿,发热。使用实施例1制得的熏蒸液熏蒸一次,症状缓解,红肿消退,第二次就可以下地走路,坚持熏蒸一个疗程(28天),疼痛消失。
患者陈某,36岁,子宫囊肿,(3*2mm)并伴有盆腔积液。接受熏蒸调理(使用产品为实施例1制得的熏蒸液)一个疗程后,囊肿缩小至(3*1mm),第二个疗程后,盆腔积液,孕囊等同时消失。
患者高某,25岁,湿疹反复发作,用尽各种西药及外涂膏药均无法彻底治愈。接受中药透皮熏蒸调理一次后,红疹面积减少,瘙痒症状缓解。继续调理一个疗程后湿疹彻底痊愈。坚持治疗三个月后彻底断根,至今未复发。
患者林某,37岁,高血脂,高血糖患者坚持调理一疗程,基本恢复正常指标。
患者李某,49岁,前列腺肥大,并伴有尿频,尿急,尿不尽等症状,调理一疗程后前列腺肥大明显缩小,尿频,尿急,尿不尽症状消失。
患者王某,21岁,面瘫患者,经一个疗程调理后,面部肌肉松弛不再僵硬,喝水不漏,第二个疗程所有症状消失恢复正常达90%左右。
患者李某,61岁,妇科疾病,宫颈糜烂三度,并伴有分泌物恶臭,接受调理后第二个疗程基本康复,宫内变得光泽透亮,分泌物清澈透亮。
最后应说明的是:以上实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的精神和范围。
Claims (10)
1.一种熏蒸液,其特征在于:制备原料包含:
2.根据权利要求1所述的熏蒸液,其特征在于:制备原料包含:
3.根据权利要求1所述的熏蒸液,其特征在于:制备原料包含:
4.权利要求1至3任一项所述熏蒸液的制备方法,其特征在于:包括如下步骤:
(1)将制备原料洗净、烘干,然后进行灭菌处理;
(2)将制备原料粉碎;
(3)利用二氧化碳超临界萃取技术对粉碎后的制备原料进行萃取,得到萃取物;和
(4)将萃取物和白酒混合,将混合物静置,然后过滤,收集滤液并进行灭菌处理,得到熏蒸液。
5.根据权利要求4所述的制备方法,其特征在于:在步骤(1)中,采用臭氧进行所述灭菌处理。
6.根据权利要求5所述的制备方法,其特征在于:在步骤(1)中,将制备原料置于无菌室中,用臭氧进行灭菌处理,并且灭菌时间控制在30~60分钟。
7.根据权利要求4所述的制备方法,其特征在于:在步骤(3)中,所述二氧化碳超临界萃取技术的工艺条件为:
萃取温度:40~50℃;
萃取压力:20~30MPa;
萃取时间:1~2h。
8.根据权利要求4所述的制备方法,其特征在于:在步骤(4)中,所述白酒和所述萃取物的质量比为(10~20):1。
9.根据权利要求4所述的制备方法,其特征在于:在步骤(4)中,将所述混合物静置1~3个月。
10.权利要求1至3任一项所述熏蒸液的使用方法,其特征在于:
将所述熏蒸液与醋按照1:(8~10)的体积比混合,将混合物放入熏蒸用装置中并进行加热。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810075346.6A CN108159276A (zh) | 2018-01-26 | 2018-01-26 | 一种熏蒸液及其制备方法和使用方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810075346.6A CN108159276A (zh) | 2018-01-26 | 2018-01-26 | 一种熏蒸液及其制备方法和使用方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108159276A true CN108159276A (zh) | 2018-06-15 |
Family
ID=62515963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810075346.6A Pending CN108159276A (zh) | 2018-01-26 | 2018-01-26 | 一种熏蒸液及其制备方法和使用方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108159276A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112043790A (zh) * | 2020-10-22 | 2020-12-08 | 浙江中医药大学 | 一种肺阴不足型干眼症熏蒸液及其制备 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101214327A (zh) * | 2007-12-31 | 2008-07-09 | 陈铁雷 | 结合温灸用的祛除风寒湿邪的外涂中药 |
| CN104147135A (zh) * | 2014-08-22 | 2014-11-19 | 王卓倬 | 一种复合熏蒸液及其制备方法 |
-
2018
- 2018-01-26 CN CN201810075346.6A patent/CN108159276A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101214327A (zh) * | 2007-12-31 | 2008-07-09 | 陈铁雷 | 结合温灸用的祛除风寒湿邪的外涂中药 |
| CN104147135A (zh) * | 2014-08-22 | 2014-11-19 | 王卓倬 | 一种复合熏蒸液及其制备方法 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112043790A (zh) * | 2020-10-22 | 2020-12-08 | 浙江中医药大学 | 一种肺阴不足型干眼症熏蒸液及其制备 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105615443A (zh) | 一种改善睡眠的药枕 | |
| CN106421663A (zh) | 一种治疗风湿骨病的药物组合物及其制备方法 | |
| CN103768567B (zh) | 一种黑膏药及其制备方法 | |
| CN104940727A (zh) | 一种治疗鼻炎的膏剂及其制备方法 | |
| CN103705751B (zh) | 用于治疗风湿腰痛的中药组合物及其制备方法 | |
| CN103316146B (zh) | 一种麻醉用中药制剂 | |
| CN104815295A (zh) | 一种治疗颈椎病的中药制剂 | |
| CN102178877B (zh) | 一种治疗阴囊湿疹的外用制剂及其制备方法 | |
| CN104689066A (zh) | 一种用于治疗烧伤的中药组合物及其制备方法 | |
| CN103182039B (zh) | 一种治疗梅毒的药物及其制备方法 | |
| CN103877247A (zh) | 用于治疗褥疮的药物及其制备方法 | |
| CN106902252A (zh) | 一种用于治疗褥疮、口腔溃疡、痔疮和肛裂的中药制剂 | |
| CN101164600A (zh) | 一种治疗痤疮、青春痘的药物 | |
| CN104324340A (zh) | 一种治疗跟骨骨质增生的中药制剂及其制备方法 | |
| CN107095905A (zh) | 一种保健灸条及灸膏 | |
| CN105031013A (zh) | 一种治疗腰椎骨质增生的药物及其制备方法 | |
| CN109999157A (zh) | 一种治疗风寒湿痹、手足拘挛、骨节疼痛的药膏 | |
| CN108159276A (zh) | 一种熏蒸液及其制备方法和使用方法 | |
| CN105999117A (zh) | 用于经络发疱拔罐排毒的中药膏贴的制备及其使用方法 | |
| CN104998074A (zh) | 一种治疗胃病的中药及其制备方法 | |
| CN104800610A (zh) | 一种治疗帕金森病的中药制剂及其制备方法 | |
| CN115154550B (zh) | 一种治疗溃疡型淋巴结结核的外用中药组合物 | |
| CN104383175A (zh) | 一种用于治疗慢性骨髓炎的药物及制备方法 | |
| CN106668295A (zh) | 一种治疗牛皮癣的外用药物及其制备方法 | |
| CN106214831A (zh) | 一种治疗白癜风的内服中药丸及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180615 |